ABSTRACT
Background The architectural design of hospitals worldwide is centred around individual departments, which require the movement of patients between wards. However, patients do not always take the simplest route from admission to discharge, but can experience convoluted movement patterns, particularly when bed availability is low. Few studies have explored the impact of these rarer, atypical trajectories.
Methods Using a mixed-method explanatory sequential study design, we firstly used three continuous years of electronic health record data prior to the Covid-19 pandemic, from 55,152 patients admitted to a London hospital network to define the ward specialities by patient type using the Herfindahl-Hirschman index. We explored the impact of ‘regular transfers’ between pairs of wards with shared specialities, ‘atypical transfers’ between pairs of wards with no shared specialities and ‘site transfers’ between pairs of wards in different hospital site locations, on length of stay, 30-day readmission and mortality. Secondly, to understand the possible reasons behind atypical transfers we conducted three focus groups and three interviews with site nurse practitioners and bed managers within the same hospital network.
Results We found that at least one atypical transfer was experienced by 12.9% of patients. Each atypical transfer is associated with a larger increase in length of stay, 2.84 days (95%CI: 2.56-3.12), compared to regular transfers, 1.92 days (95%CI: 1.82-2.03). No association was found between odds of mortality, or 30-day readmission and atypical transfers after adjusting for confounders. Atypical transfers appear to be driven by complex patient conditions, a lack of hospital capacity, the need to reach specific services and facilities, and more exceptionally, rare events such as major incidents.
Conclusion Our work provides an important first step in identifying unusual patient movement and its impacts on key patient outcomes using a system-wide, data-driven approach. The broader impact of moving patients between hospital wards, and possible downstream effects should be considered in hospital policy and service planning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was co-funded by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC) and the Economic and Social Research Council (ESRC). EM is supported by the ESRC (grant number ES/ P000703/1) as part of the ESRC London Interdisciplinary Social Science Doctoral Training Partnership. PE is partially supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC) (grant number NIHR-BRC-P68711). KH is supported by the NIHR [HS&DR] Project: NIHR129082.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was defined as service evaluation by the Health Service Research Authority and therefore NHS Research Ethics Committee approval was not needed. The study was approved as a service evaluation through Imperial College Healthcare NHS Trust (Ref:347/Ref:719) Ethical research practice standards were followed throughout, including obtaining informed consent and right to withdraw from the study at any point.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Paul Expert and Ceire Costelloe should be considered joint senior authors.
↵* e.mendelsohn18{at}imperial.ac.uk
Data Availability
Data may be obtained from a third party and are not publicly available. Deidentified patient data cannot be made publicly available due to information governance restrictions. Access to the data sets used in this paper via a secure environment will be reviewed on request by Imperial College Healthcare NHS Trust.
